SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Acutaas Chemicals - Quaterly Results

25 Jul 2026 Evaluate
The Turnover for the quarter ended June 2026 of Rs. 3224.09 millions increase by 56.53% from Rs. 2059.71 millions.Net profit for the quarter ended June 2026 increased significantly by 70.00% to Rs. 758.96 millions from Rs. 446.46 millions.Operating profit for the quarter ended June 2026 rose to 1141.53 millions as compared to 670.09 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 3224.09 2059.71 56.53 3224.09 2059.71 56.53 13237.92 9898.35 33.74
Other Income 44.76 160.20 -72.06 44.76 160.20 -72.06 458.78 183.36 150.21
PBIDT 1141.53 670.09 70.35 1141.53 670.09 70.35 5288.83 2434.78 117.22
Interest 11.18 6.20 80.32 11.18 6.20 80.32 30.77 58.57 -47.46
PBDT 1130.35 663.89 70.26 1130.35 663.89 70.26 5258.06 2376.21 121.28
Depreciation 90.20 74.62 20.88 90.20 74.62 20.88 330.32 240.45 37.38
PBT 1040.15 589.27 76.52 1040.15 589.27 76.52 4927.74 2135.76 130.73
TAX 281.19 142.81 96.90 281.19 142.81 96.90 1265.99 540.29 134.32
Deferred Tax 25.87 15.53 66.58 25.87 15.53 66.58 111.09 70.58 57.40
PAT 758.96 446.46 70.00 758.96 446.46 70.00 3661.75 1595.47 129.51
Equity 409.36 409.34 0.00 409.36 409.34 0.00 409.36 409.34 0.00
PBIDTM(%) 35.41 32.53 8.83 35.41 32.53 8.83 39.95 24.60 62.42

Acutaas Chemicals Share Price

3257.15 -198.75 (-5.75%)
24-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1941.00
Dr. Reddys Labs. 1152.60
Cipla 1410.90
Lupin 2369.45
Zydus Lifesciences 1108.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: